The parties overlap on the provision of private medical oncology services in Singapore.
The proposed acquisition of TalkMed Group by Tamarind Health has been cleared by the Competition and Consumer Commission of Singapore (CCCS) on June 27.
The competition watchdog says that it has assessed that the proposed transaction will not infringe the section 54 prohibition of the act, which prohibits mergers that may substantially lessen competition within any market in Singapore.
